Press Releases by "R-Tech Ueno, Ltd."

• Basic agreement on the licensing of data of recombinant human serum albumin
  [ Pharmaceuticals | 2011-10-19]
• Basic agreement on the supply of recombinant human serum albumin
  [ Pharmaceuticals | 2011-10-18]
• Announcement of the Execution of a License Agreement for Unoprostone
  [ Pharmaceuticals | 2011-03-22]
• Donation for the Area Stricken by the 2011 Tohoku Pacific Offshore Earthquake
  [ Pharmaceuticals | 2011-03-18]
• Notice regarding effect of Tohoku Pacific Offshore Earthquake
  [ Pharmaceuticals | 2011-03-17]
• R-Tech Ueno Initiates a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes
  [ Pharmaceuticals | 2011-02-09]
• Notification to the completion of the Phase 2a clinical study of RK-023 to treat androgenetic alopecia
  [ Pharmaceuticals | 2011-01-24]
• Sucampo Initiates Third Phase 3 Clinical Trial of Lubiprostone
  [ Pharmaceuticals | 2011-01-13]
• Sucampo Pharmaceuticals Submits Marketing Application to Japanese Regulatory Authorities for AMITIZA® (lubiprostone)
  [ Pharmaceuticals | 2010-10-12]
• R-Tech Ueno Submits a Request for Arbitration against Takeda Pharmaceutical
  [ Pharmaceuticals | 2010-08-16]
• Announcement of Change in Storage Condition for Rescula® Eye Drops 0.12%
  [ Pharmaceuticals | 2010-07-22]
• Notification related to the Completion of the Phase II Clinical Study of the Ophthalmic Solution UF-021 (product name Ocuseva(TM)) on Retinitis Pigmentosa (2)
  [ Pharmaceuticals | 2010-07-15]
• Announcement of Termination of Licensing Agreement for Rescula® Eye Drops
  [ Pharmaceuticals | 2010-07-02]
• Lubiprostone Successfully Completes Phase 3 Efficacy Trial in Japanese Patients
  [ Pharmaceuticals | 2010-06-10]
• Notification related to the Completion of the Phase II Clinical Study of UF-021 (product name Ocuseva(TM)) on Retinitis Pigmentosa
  [ Pharmaceuticals | 2010-06-03]
• Announcement of License Agreement for Rescula® Eye Drops with Novartis Pharma
  [ Pharmaceuticals | 2010-05-13]
• R-Tech Ueno's Sanda Factory Passes Inspection for the Manufacture of Rescula® Eye Drops
  [ Pharmaceuticals | 2010-05-06]
• R-Tech Ueno Starts Contract Manufacturing of Liquid-filled Capsules
  [ Pharmaceuticals | 2010-04-28]
• Notification Regarding the Application for Marketing Approval of Latanoprost Eye Drops 0.005% in Japan
  [ Pharmaceuticals | 2010-04-05]
• Announcement of Revision in Sales Method for Rescula® Eye Drops 0.12% in South Korea and Taiwan
  [ Pharmaceuticals | 2010-03-30]

Most Popular: "R-Tech Ueno, Ltd."